HSHHSH Health Technology Supplier Hub
Home › Suppliers › Medtronic › Risk

Medtronic: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

FY2026 revenue $36.36bn (+8.4%); operating margin 17.8%; net income $4.80bn.

Balance sheet figures not captured from release.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

Mar 2026: Medtronic completed the carve-out of its diabetes business, MiniMed Group, which listed separately on Nasdaq.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

Apr 2026: Medtronic disclosed a breach of its corporate IT systems after the ShinyHunters group claimed to hold over 9 million records; Medtronic said products, patient safety and manufacturing were not affected. Several proposed class actions followed. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Oct 2025: the FDA classed Medtronic's recall of DLP left heart vent catheters as Class I after 41 complaints that catheters may not hold their shape when bent; Medtronic said no deaths had been reported.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

Dec 2025: Medtronic was named one of eight suppliers on NHS Supply Chain's managed services framework lot for angiography equipment and accessories (lot value £399.5m ex VAT across all suppliers).

Researched 10 Nov 2026